Skip to content
Oncology Research Hub

Research area

Melanoma clinical trials

Studies in melanoma look at investigational immunotherapies, targeted medications, and combinations for this form of skin cancer. Whether you are reading for yourself or for someone you care for, Oncology Research Hub can help you find out if a study may be a fit.

Updated

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Melanoma studies in numbers

melanoma studies recruiting in the U.S.
245
states with a study site
51
studies that accept healthy volunteers
15

Source: ClinicalTrials.gov. Data processed .

Find melanoma studies by state

These states have the most studies recruiting right now.

Melanoma studies recruiting now

As of November 16, 2026, 245 melanoma studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.

What they test

  • medications146
  • biologics such as vaccines or antibodies48
  • other approaches40
  • procedures35
  • devices14

A study can test more than one.

Main purpose

  • treating a condition172
  • supportive care10
  • prevention6
  • other purposes5

Phase

  • Early Phase 15
  • Phase 148
  • Phase 1/252
  • Phase 249
  • Phase 2/33
  • Phase 314
  • Phase 42
  • No phase29
  • Observational43

Studies of devices and behavioral approaches have no phase.

Who runs them

  • university, hospital or other146
  • industry91
  • government8

Who they enroll

  • adults (18 to 64)242
  • older adults (65 and over)235
  • children (under 18)21

15 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 245 studies.

Recently updated melanoma studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. Molecular Analysis of Childhood and Adolescent Melanocytic Lesions

    • Observational
    • Up to age 18
    • All sexes
    Sponsor
    St. Jude Children's Research Hospital
    Recruiting in
    Memphis, TN
    Registry record
    NCT02775643 · updated
  2. Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Pittsburgh, PA
    Registry record
    NCT07040280 · updated
  3. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Albuquerque, NM · Anaconda, MT · Arroyo Grande, CA · and 140 more U.S. locations
    Registry record
    NCT07068074 · updated
  4. A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Aurora, CO · Boston, MA · Chicago, IL · and 4 more U.S. locations
    Registry record
    NCT02332668 · updated
  5. Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston, TX
    Registry record
    NCT04751396 · updated
  6. Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Utah
    Recruiting in
    Salt Lake City, UT
    Registry record
    NCT04844528 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in the United States on ClinicalTrials.gov.

What melanoma studies look at

Research into melanoma, a form of skin cancer, examines investigational immunotherapies, targeted medications, and combinations. A single question sits at the center of each trial. Because that question differs from trial to trial, so do the tasks you, or the person you are reading for, might be given.

Investigational is the word for anything being tested in a trial. It means the answers about how well it works, and about its risks, are not yet in. Finding those answers is why the trial exists.

Who may be able to take part

Requirements are set separately for each study. Age, health history, current medications, and how a condition affects you can all be part of them. People who do not have the condition are also enrolled in some studies.

Working out eligibility is not something you have to do yourself. It is checked by the study team at a screening visit. Read how eligibility and screening work.

What taking part usually involves

  1. A first conversation

    Before anything else happens, a coordinator describes the study in general terms. Your questions are answered at this point too.

  2. Informed consent

    Everything about the study, including the risks known so far, is put in writing for you by the study team. Agreeing or not is your choice.

  3. Screening

    The team asks health questions and runs tests to see whether the study suits you. Some people who are screened do not go on to take part.

  4. Study visits

    Joining means coming in for visits on a set schedule. These let the team keep track of your health. You remain free to stop taking part at any point.

Questions about melanoma studies

Do I need a diagnosis to join a study about melanoma?

This varies by study. A confirmed diagnosis is required for some, while in others you are assessed during screening. You will hear from the study team which applies to you.

Would I have to change the care I receive now?

Please make no changes to any care by yourself. Whether current care carries on alongside a study varies: it is permitted in some studies and not in others. This is something the study doctor reviews with you. Before you decide, you are also free to discuss it with your own doctor.

Is there a cost to take part?

In general, people taking part in a cancer study are not charged for its visits, its tests, or its medication. See the details on costs.

Ask about melanoma studies

A coordinator will get in touch once you have shared a few details. You are not committing to anything by asking.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call